Related Experiment Video
Updated: Apr 2, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Relation between the serum ferritin level and the risk for acute myocardial infarction
Mehdi Moradi1, Farnaz Fariba2, Ali Sadeghi Mohasseli2
1Cardiovascular Research Center of Ekbatan Hospital, Hamadan University of Medical Sciences, Hamadan, Iran. mmorad341@yahoo.com.
Insights
Elevated serum ferritin levels are a strong predictor of acute myocardial infarction (AMI), particularly ST-elevation myocardial infarction (STEMI). This finding suggests iron stores may play a role in cardiac events.
Area of Science:
- Cardiology
- Biochemistry
- Internal Medicine
Background:
- Increased body iron stores are suspected to increase acute myocardial infarction (AMI) risk.
- The role of serum ferritin as an independent risk factor for cardiac events remains debated.
- This study investigates the association between serum ferritin levels and AMI incidence.
Purpose of the Study:
- To assess the association between serum ferritin levels and the incidence of acute myocardial infarction (AMI).
- To determine if serum ferritin is an independent predictor of AMI, specifically ST-elevation myocardial infarction (STEMI).
Main Methods:
- A case-control study involving 100 male patients with first AMI (50 STEMI, 50 NSTEMI) and 50 controls.
- Serum ferritin levels were measured using ELISA on the first and fifth days post-admission.
- Statistical analysis included multivariable logistic regression adjusted for age and risk factors.
Main Results:
- Serum ferritin concentrations were significantly higher in STEMI and NSTEMI groups compared to controls.
- Median ferritin levels were highest in the STEMI group (159 µg/dl), followed by NSTEMI (146 µg/dl) and controls (32.5 µg/dl).
- Elevated serum ferritin predicted STEMI occurrence (OR = 5.1, P = 0.017) after adjusting for covariates.
Conclusions:
- Elevated serum ferritin is a potent predictor of AMI, especially STEMI.
- Serum ferritin levels may serve as a valuable biomarker for assessing cardiac event risk.
- Further research is warranted to elucidate the mechanisms linking iron stores and myocardial infarction.
Background:
Increased estimated body iron stores have been recently suggested to be associated with increased risk of acute myocardial infarction (AMI); however the question of whether serum ferritin level as an indicator for estimating body iron is an independent risk factor for cardiac events is still questioned. In the present study, we assessed whether serum ferritin was associated with the incidence of AMI.
Methods:
The study population consisted of 100 consecutive male patients with first AMI (50 suffered STEMI and 50 with NSTEMI diagnosis) admitted within 12 hours of the onset of chest pain to coronary care units (CCU) at Ekbatan hospital in the city of Hamadan, Iran. A control group (n = 50) was also randomly selected among men without any evidences of AMI from same hospital. Serum ferritin was measured using an ELISA assay by a special kit at the first and fifth days after admission.
Results:
The first and fifth day serum ferritin concentrations averaged 56.75 and 112.5 µg/dl in STEMI (ST Elevation Myocardial Infarction) group, 36.5 and 87.25 µg/dl in NSTEMI (Non ST Elevation Myocardial Infarction)group and 22.5 and 42.0 µg/dl in control group that was significantly higher in former group. In this regard, the medium level of ferritin in STEMI, NSTEMI, and control groups were 159, 146, and 32.5 µg/dl, respectively that was significantly higher in those who suffered STEMI than in other study subgroups (p < 0.001). Multivariable logistic regression model showed that the elevated level of serum ferritin could predict occurrence of STEMI adjusted for initial ferritin concentration, patients' age and coronary disease risk factors (OR = 5.1, P = 0.017).
Conclusions:
Elevated serum ferritin can be a potent factor for predicting AMI especially STEMI.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Acute Coronary Syndrome I: Introduction
Myocarditis I: Introduction

